Boston Scientific's total assets for Q1 2026 were $44.35B, an increase of 1.55% from the previous quarter. BSX total liabilities were $18.25B for the fiscal quarter, a -4.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.